CompletedPhase 4

Incidence and Severity of Residual Neuromuscular Blockade

United States78 participantsStarted 2016-01

Plain-language summary

This prospective study will take place at Harborview Medical Center (HMC) and the University of Washington Medical Center (UWMC), and will enroll adult patients undergoing abdominal surgery. The purpose of this study is to identify if the use of a specific plan to managing muscle relaxants will help decrease the risk of muscle weakness after general anesthesia with muscle relaxation in a population of patients undergoing abdominal surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults age 18 or older * Will undergo open or laparoscopic abdominal surgery expected to last \<6 hours at HMC or UWMC * Have ASA physical status I-III * Scheduled to have general anesthesia with at least 1 dose of nondepolarizing NMBD for endotracheal intubation or maintenance of neuromuscular block (NMB) Exclusion Criteria: * Allergy to NMBDs * Patients with neuromuscular disease (myasthenia gravis or muscular dystrophy) * Pregnant or lactating women * Non-English speaking * Unable to provide informed consent

What they're measuring

Incidence of residual paralysis

Timeframe: The outcome measure will be assessed at time of extubation

Trial details

NCT IDNCT02660398

SponsorUniversity of Washington

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-01

View on ClinicalTrials.gov More Residual Neuromuscular Blockade trials